We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
From Treatable Traits to Personalized Medicine in COPD: T2 Inflammation and Its Impact on Patient Assessment and Treatment
Surya Bhatt, MD
MeiLan Han, MD, MS
Breathing Through the Burden of COPD
Molecular Mechanisms of COPD
Going Beyond Today’s Assessments to Confirm COPD, Are Biomarkers Key?
Insights to Pharmaceutical Approaches in COPD
Putting Theory Into Practice: Mastering Management of COPD
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Martha Kingman, DNP, FNP-C
Susanne McDevitt, DNP, ACNP-BC
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Jean M. Elwing, MD
Nicholas Kolaitis, MD, MAS
Katharine Clapham, MD
Advancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patient-Centered Care
Denis Hadjiliadis, MD, MHS, PhD
Gregory S. Sawicki, MD, MPH
Alexandra Wilson, MS, RDN, CDE
Susanna A. McColley, MD
Updates From the 7th World Symposium Task Force
Eric D. Austin, MD, MSCI
Hilary M. DuBrock, MD
H. James Ford, MD
Gustavo A. Heresi, MD, MS
Gergely Meszaros, JD, MSc
Oksana A. Shlobin, MD
Ioana Preston, MD
Lucilla Piccari, MD, PhD
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
Farrukh Abbas, MD
Megan Conroy, MD, MA(Ed)
The Evolving Role of MET TKIs in NSCLC
Gilberto de Lima Lopes, Jr, MD, MBA, FASCO
Jyoti Patel, MD
The Next Generation of Treatment for Patients With PH
Richard N. Channick, MD
Vallerie V. McLaughlin, MD
Are the current guidelines current?
Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education